NASDAQ:LHCG - LHC Group Stock Price, Forecast & News

LHC Group trades on the NASDAQ under the ticker symbol "LHCG."

LHC Group, Inc. (NASDAQ:LHCG) released its quarterly earnings results on Wednesday, November, 6th. The health services provider reported $1.26 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $1.08 by $0.18. The health services provider had revenue of $528.50 million for the quarter, compared to the consensus estimate of $534.15 million. LHC Group had a net margin of 4.59% and a return on equity of 9.39%. LHC Group's revenue was up 4.2% compared to the same quarter last year. During the same period in the prior year, the company posted $0.95 earnings per share. View LHC Group's Earnings History.

LHC Group is scheduled to release their next quarterly earnings announcement on Wednesday, February 26th 2020. View Earnings Estimates for LHC Group.

LHC Group issued an update on its FY19 earnings guidance on Wednesday, November, 6th. The company provided EPS guidance of $4.35-4.45 for the period, compared to the Thomson Reuters consensus estimate of $4.33. The company issued revenue guidance of $2.09-2.14, compared to the consensus revenue estimate of $2.10 billion.

11 Wall Street analysts have issued 12-month price objectives for LHC Group's shares. Their forecasts range from $114.00 to $160.00. On average, they expect LHC Group's share price to reach $133.80 in the next year. This suggests that the stock has a possible downside of 9.0%. View Analyst Price Targets for LHC Group.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LHC Group in the last year. There are currently 3 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for LHC Group.

Media headlines about LHCG stock have been trending somewhat positive on Wednesday, according to InfoTrie. The research group rates the sentiment of media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. LHC Group earned a news impact score of 2.0 on InfoTrie's scale. They also gave news stories about the health services provider a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for LHC Group.

LHC Group saw a decline in short interest in the month of December. As of December 13th, there was short interest totalling 1,740,000 shares, a decline of 7.4% from the November 28th total of 1,880,000 shares. Based on an average daily trading volume, of 201,100 shares, the days-to-cover ratio is currently 8.7 days. Approximately 5.8% of the shares of the company are short sold. View LHC Group's Current Options Chain.

Some companies that are related to LHC Group include Laboratory Corp. of America (LH), Quest Diagnostics (DGX), Davita (DVA), Chemed (CHE), Amedisys (AMED), AMN Healthcare Services (AMN), BioScrip (BIOS), MEDNAX (MD), CorVel (CRVL), R1 RCM (RCM), Tivity Health (TVTY), The Providence Service (PRSC), Cross Country Healthcare (CCRN) and Interpace Diagnostics Group (IDXG).

Based on aggregate information from My MarketBeat watchlists, some companies that other LHC Group investors own include Verizon Communications (VZ), Home Depot (HD), Cisco Systems (CSCO), Alibaba Group (BABA), Visa (V), CVS Health (CVS), Chevron (CVX), Exxon Mobil (XOM), NVIDIA (NVDA) and Walt Disney (DIS).

LHC Group's stock is owned by a number of of retail and institutional investors. Top institutional investors include Tributary Capital Management LLC (0.85%), Summit Creek Advisors LLC (0.54%), Copper Rock Capital Partners LLC (0.52%), Scout Investments Inc. (0.29%), Janney Montgomery Scott LLC (0.22%) and First National Bank of Omaha (0.17%). Company insiders that own LHC Group stock include Donald Dwayne Stelly, Jeff Reibel, John L Indest, Joshua L Proffitt, Keith G Myers, Ronald T Nixon and Tyree G Wilburn. View Institutional Ownership Trends for LHC Group.

LHCG stock was sold by a variety of institutional investors in the last quarter, including Tributary Capital Management LLC, Scout Investments Inc., First National Bank of Omaha, Louisiana State Employees Retirement System, State of Alaska Department of Revenue, Janney Montgomery Scott LLC, Calamos Advisors LLC and NEXT Financial Group Inc. Company insiders that have sold LHC Group company stock in the last year include Donald Dwayne Stelly, John L Indest, Joshua L Proffitt, Keith G Myers and Ronald T Nixon. View Insider Buying and Selling for LHC Group.

LHCG stock was acquired by a variety of institutional investors in the last quarter, including Summit Creek Advisors LLC, Copper Rock Capital Partners LLC, Meridian Wealth Management LLC, Assenagon Asset Management S.A. and Zurcher Kantonalbank Zurich Cantonalbank . View Insider Buying and Selling for LHC Group.

Shares of LHCG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of LHCG stock can currently be purchased for approximately $147.08.

LHC Group has a market capitalization of $4.63 billion and generates $1.81 billion in revenue each year. The health services provider earns $63.57 million in net income (profit) each year or $3.55 on an earnings per share basis. LHC Group employs 30,985 workers across the globe.View Additional Information About LHC Group.

The official website for LHC Group is http://www.lhcgroup.com/.

LHC Group's mailing address is 901 HUGH WALLIS ROAD SOUTH, LAFAYETTE LA, 70508. The health services provider can be reached via phone at 337-233-1307 or via email at [email protected]